CVE-2024-9518

UserPlus <= 2.0 - Unauthenticated Privilege Escalation

Description

The UserPlus plugin for WordPress is vulnerable to privilege escalation in versions up to, and including, 2.0 due to insufficient restriction on the 'form_actions' and 'userplus_update_user_profile' functions. This makes it possible for unauthenticated attackers to specify their user role by supplying the 'role' parameter during a registration.

Category

9.8
CVSS
Severity: Critical
CVSS 3.1 •
EPSS 0.16%
Third-Party Advisory wordfence.com
Affected: userplus User registration & user profile – UserPlus
Published at:
Updated at:

References

Link Tags
https://www.wordfence.com/threat-intel/vulnerabilities/id/2489e649-27f7-4ca0-8655-0957016fa89a?source=cve third party advisory
https://plugins.trac.wordpress.org/browser/userplus/trunk/functions/user-functions.php?rev=1604604#L47 product

Frequently Asked Questions

What is the severity of CVE-2024-9518?
CVE-2024-9518 has been scored as a critical severity vulnerability.
How to fix CVE-2024-9518?
To fix CVE-2024-9518, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-9518 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-9518 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-9518?
CVE-2024-9518 affects userplus User registration & user profile – UserPlus.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.